Is the metabolic syndrome caused by a high fructose, and relatively low fat, low cholesterol diet?
- PMID: 22291727
- PMCID: PMC3258689
- DOI: 10.5114/aoms.2011.20598
Is the metabolic syndrome caused by a high fructose, and relatively low fat, low cholesterol diet?
Abstract
The metabolic syndrome (MetS) is manifested by a lipid triad which includes elevated serum triglycerides, small LDL particles, and low high-density lipoprotein (HDL) cholesterol, by central obesity (central adiposity), insulin resistance, glucose intolerance and elevated blood pressure, and it is associated with an increased risk of type 2 diabetes and coronary heart disease. We have developed a new hypothesis regarding MetS as a consequence of a high intake in carbohydrates and food with a high glycemic index, particularly fructose, and relatively low intake of cholesterol and saturated fat. We support our arguments through animal studies which have shown that exposure of the liver to increased quantities of fructose leads to rapid stimulation of lipogenesis and accumulation of triglycerides. The adipocytes store triglycerides in lipid droplets, leading to adipocyte hypertrophy. Adipocyte hypertrophy is associated with macrophage accumulation in adipose tissue. An important modulator of obesity-associated macrophage responses in white adipose tissue is the death of adipocytes. Excess exposure to fructose intake determines the liver to metabolize high doses of fructose, producing increased levels of fructose end products, like glyceraldehyde and dihydroxyacetone phosphate, that can converge with the glycolytic pathway. Fructose also leads to increased levels of advanced glycation end products. The macrophages exposed to advanced glycation end products become dysfunctional and, on entry into the artery wall, contribute to plaque formation and thrombosis.
Keywords: cholesterol; fructose; metabolic syndrome.
Figures
Similar articles
-
The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease.Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):464-72. doi: 10.1016/j.pcad.2015.11.006. Epub 2015 Nov 14. Prog Cardiovasc Dis. 2016. PMID: 26586275 Free PMC article. Review.
-
Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.Am J Physiol Endocrinol Metab. 2016 Mar 15;310(6):E418-39. doi: 10.1152/ajpendo.00319.2015. Epub 2015 Dec 15. Am J Physiol Endocrinol Metab. 2016. PMID: 26670487 Free PMC article.
-
Dual probiotic strains suppress high fructose-induced metabolic syndrome.World J Gastroenterol. 2013 Jan 14;19(2):274-83. doi: 10.3748/wjg.v19.i2.274. World J Gastroenterol. 2013. PMID: 23345951 Free PMC article.
-
The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.Metabolism. 2013 Dec;62(12):1840-9. doi: 10.1016/j.metabol.2013.08.001. Epub 2013 Sep 13. Metabolism. 2013. PMID: 24035454
-
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005. Am J Cardiovasc Drugs. 2005. PMID: 16259526 Review.
Cited by
-
Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.Arch Med Sci. 2013 Feb 21;9(1):166-71. doi: 10.5114/aoms.2013.33356. Arch Med Sci. 2013. PMID: 23515589 Free PMC article. Review.
-
Biochemistry of adipose tissue: an endocrine organ.Arch Med Sci. 2013 Apr 20;9(2):191-200. doi: 10.5114/aoms.2013.33181. Epub 2013 Feb 10. Arch Med Sci. 2013. PMID: 23671428 Free PMC article.
-
Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats.BMC Complement Med Ther. 2021 Mar 30;21(1):104. doi: 10.1186/s12906-021-03275-5. BMC Complement Med Ther. 2021. PMID: 33785007 Free PMC article.
-
Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?Rev Diabet Stud. 2013 Summer-Fall;10(2-3):171-90. doi: 10.1900/RDS.2013.10.171. Epub 2013 Aug 10. Rev Diabet Stud. 2013. PMID: 24380091 Free PMC article. Review.
-
Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate.Arch Med Sci. 2013 Apr 20;9(2):238-42. doi: 10.5114/aoms.2013.34537. Epub 2013 Apr 9. Arch Med Sci. 2013. PMID: 23671433 Free PMC article.
References
-
- Redon J, Martinez F, Fabia MJ. The metabolic syndrome in hypertension. Arch Med Sci. 2009;5:S320–9.
-
- Grundy SM, Brewer BH, Jr, Cleeman JI, Smith SC, Jr, Lenfant C. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation. 2004;109:433–8. - PubMed
-
- Ferrannini E. Metabolic syndrome: a solution in search of a proble(m. J Clin Endocrinol Metabol. 2007;92:396–8. - PubMed
-
- Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA. The metabolic syndrome in cancer survivors. Lancet Oncol. 2010;11:193–203. - PubMed
-
- Jeppesen J, Hein HO, Suadicani P, Gynterberg F. Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease. Arch Intern Med. 2001;16:361–6. - PubMed
LinkOut - more resources
Full Text Sources